Kanji Hussein D, McCallum Jessica, Norena Monica, Wong Hubert, Griesdale Donald E, Reynolds Steven, Isac George, Sirounis Demetrios, Gunning Derek, Finlayson Gordon, Dodek Peter
Royal Columbian Hospital, Vancouver BC, Canada; Division of Critical Care Medicine, University of British Columbia, Vancouver, BC, Canada; Vancouver General Hospital, Vancouver, BC, Canada.
Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
J Crit Care. 2016 Jun;33:169-73. doi: 10.1016/j.jcrc.2016.01.010. Epub 2016 Jan 13.
The purpose of the study is to compare outcomes in patients who had severe hypoxemic respiratory failure (Pao2/fraction of inspired oxygen <100) who received early veno-venous extracorporeal membrane oxygenation (ECMO) as an adjunct to mechanical ventilation, to those in patients who received conventional mechanical ventilation alone.
This is a multicenter, retrospective unmatched and matched cohort study of patients admitted between April 2006 and December 2013. Generalized logistic mixed-effects models and Cox proportional hazards models were used to determine the association between treatment with ECMO that was started within 3 days of intensive care unit (ICU) admission and ICU and hospital mortality and length of stay, respectively.
A total of 2440 patients who had severe hypoxemic respiratory failure due to various etiologies were included, 46 who received early veno-venous ECMO and 2394 unmatched and 398 matched controls who received conventional ventilation alone. Compared to matched controls, ECMO was associated with a lower odds of ICU (odds ratio [95% confidence interval], 0.30 [0.13-0.67]) and inhospital death (odds ratio 0.30 [0.14-0.67]). In addition, ECMO was associated with longer times to discharge from ICU and hospital (hazard ratio, 0.42 [0.37-0.47] and 0.53 [0.38-0.73], respectively).
In this observational study, use of early ECMO compared to conventional mechanical ventilation alone in patients who had severe hypoxemic respiratory failure was associated with a lower risk of mortality and a longer length of stay.
本研究旨在比较因严重低氧血症性呼吸衰竭(动脉血氧分压/吸入氧分数<100)接受早期静脉-静脉体外膜肺氧合(ECMO)作为机械通气辅助治疗的患者与仅接受传统机械通气患者的治疗结果。
这是一项对2006年4月至2013年12月期间入院患者进行的多中心、回顾性非匹配和匹配队列研究。使用广义逻辑混合效应模型和Cox比例风险模型分别确定在重症监护病房(ICU)入院3天内开始使用ECMO治疗与ICU死亡率、医院死亡率及住院时间之间的关联。
共纳入2440例因各种病因导致严重低氧血症性呼吸衰竭的患者,其中46例接受早期静脉-静脉ECMO治疗,2394例非匹配及398例匹配对照仅接受传统通气治疗。与匹配对照相比,ECMO治疗组的ICU死亡几率(优势比[95%置信区间],0.30[0.13 - 0.67])和院内死亡几率(优势比0.30[0.14 - 0.67])较低。此外,ECMO治疗组从ICU出院和从医院出院的时间更长(风险比分别为0.42[0.37 - 0.47]和0.53[0.38 - 0.73])。
在这项观察性研究中,对于严重低氧血症性呼吸衰竭患者,与仅使用传统机械通气相比,早期使用ECMO与较低的死亡风险和更长的住院时间相关。